The goal of this clinical trial is to learn the differences severity level of diabetic neuropathy based on electromyelography in type II diabetic patient with and without comorbidities. The main questions of this study:

1. What is the electromyography result in type II diabetic patient who: has no comorbidities, with hypertension, with hypertension and dyslipidemia?
2. Is there any differences in electromyography result in type II diabetic patient who: has no comorbidities, with hypertension, with hypertension and dyslipidemia?
3. Is there any association between distal latency with nerve conduction velocity in type II diabetic patient with and without comorbidities?
4. Is there any association between distal latency with amplitude in type II diabetic patient with and without comorbidities?
5. Is there any differences on diabetic neuropathy severity based on age, height, and A1C levels in type II diabetic patient with and without comorbidities?

Researchers will collect information based on hospital registry as secondary data of in type II diabetic patient with and without comorbidities. The data consist of demographic data, clinical presentation, laboratory, and electromyography were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Inclusion Criteria:

• Diabetic neuropathy patient who classified as distal symmetrical polyneuropathy
• Diabetic neuropathy patient who has no comorbidities
• Diabetic neuropathy patient who has hypertension
• Diabetic neuropathy patient who has hypertension and dyslipidemia

Exclusion Criteria:

• Diabetic neuropathy patient with history of chemotherapy
• Diabetic neuropathy patient with history of hernia nucleus pulposus
• Diabetic neuropathy patient with history of CKD stage V or on routine dyalisis
• Missing data on medical record

Patient with type II diabetic mellitus who suffered diabetic neuropathy which diagnosed by using electromyography and fulfill the eligibility criteria